14
Jul
2010
Maximal Targeted Inhibition of Androgen Signaling for Prostate Cancer Therapy Project Leader: Peter Nelson, M.D. Co-leader: Paul Lange, M.D. Clinical and laboratory evidence continues to demonstrate that androgens and the androgen receptor (AR) are the best available targets for treating/preventing both early and advanced prostate cancer. Numerous clinical trials have
